Evidence map›Paper›PMID 39507983›Full record

ArticleSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2024

[Distribution of the Pathogens Isolated from 6428 Tumor Patients in 2019-2023 and the Relevant Drug Resistance Surveillance Report].

Qiuping Tang, Yuanfang Wang, Yu Yuan, Ling Shu, Jin Deng, Chao He

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qiuping Tang（ 610041） Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Yuanfang Wang（ 610041） Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Yu Yuan（ 610041） Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Ling Shu（ 610041） Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Jin Deng（ 610041） Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Chao He（ 610041） Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the characteristics of the pathogens isolated from the specimens of tumor patients and detection rates of multidrug-resistant bacteria in a hospital in the past five years, so as to provide references for infection prevention and control. Methods: The results of pathogenic culture and Results: A total of 16393 strains were isolated from 80386 specimens, producing a detection rate of 20.4%. After excluding the duplicate strains isolated from the same patients, Conclusion: Gram-negative bacteria were the prevalent pathogens of tumor patients. The detection rate of multidrug-resistant bacteria was relatively high, and the detection rate of methicillin-resistant

Indexed as

Drug Resistance, Multiple, BacterialNeoplasmsAcinetobacter baumanniiAnti-Bacterial AgentsBacteriaCandidaEscherichia coliHumansKlebsiella pneumoniaeMicrobial Sensitivity TestsPseudomonas aeruginosaRetrospective StudiesStaphylococcus aureusAnti-Bacterial AgentsMultidrug-resistant bacteriaPathogenResistanceTumor

Identifiers

PMID39507983
PMCPMC11536249

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.